Approval · Notice of Compliance 10866 · 2009
TARGIN: Notice of Compliance 10866
Issued December 16, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10866
- Date
- December 16, 2009
- Company
- Purdue PharmaToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Opioid analgesic / Opioid Antagonist
Products in this notice
Medicinal ingredients
- OXYCODONE HYDROCHLORIDE 10 MG per TAB
- NALOXONE HYDROCHLORIDE 5 MG per TAB
- OXYCODONE HYDROCHLORIDE 20 MG per TAB
- NALOXONE HYDROCHLORIDE 10 MG per TAB
- OXYCODONE HYDROCHLORIDE 40 MG per TAB
- NALOXONE HYDROCHLORIDE 20 MG per TAB